7 Stories Sending Dow Healthcare Stocks for a Ride This Week

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Johnson & Johnson (NYSE:JNJ): Current price $81.52

Mallinckrodt, the pharmaceuticals division of Covidien, reported that it introduced the 36 and 54 milligram dosage strengths of Methylphenidate HCl Extended-Release Tablets USP, generic version of Concerta. The two dosage strengths will be available, in addition to the 27 mg dosage strength. The 27 mg dosage strength was launched in December 2012, when Mallinckrodt won approval from the FDA to manufacture and market the tablets in 27, 36, and 54 mg dosage strengths.

More than one Supreme Court justice appeared to be skeptical concerning the practice of brand name pharmaceutical firms paying generic companies to keep their less expensive drugs off the market for a longer time, according to The New York Times, which also said that some of the justices seemed to be interested in issuing a narrow ruling that would not form a precedent.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

JNJ

Don’t Miss: Which President is the King of the Fiscal Squeeze?

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business